Cannell & Co. Ionis Pharmaceuticals Inc Transaction History

Cannell & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 12, 2020	SELL	$47.45 - $62.95 $182,682 - $242,357	-3,850 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$46.85 - $61.05 $180,372 - $235,042	3,850 New	3,850 $227,000
Q1 2020 May 05, 2020	SELL	$41.6 - $63.4 $160,160 - $244,090	-3,850 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$43.37 - $59.54 $166,974 - $229,229	3,850 New	3,850 $208,000

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.1B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

Stay updated on Cannell & Co. with notifications on news.